Advanced Medical Optics Announces Release Date for First Quarter 2005 Operating Results
12 Abril 2005 - 2:10PM
PR Newswire (US)
Advanced Medical Optics Announces Release Date for First Quarter
2005 Operating Results SANTA ANA, Calif., April 12
/PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO)
(NYSE:AVO), a global leader in ophthalmic surgical devices and eye
care products, today announced it will report first quarter 2005
financial results before the market opens on Thursday, April 28,
2005. (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO)
The company will host a conference call and live web cast with
investors and analysts on Thursday, April 28, 2005, at 10:00 a.m.
EDT. To participate in the live Web cast or to access the archived
replay, please visit AMO's Investors site at
http://www.amo-inc.com/. About Advanced Medical Optics Advanced
Medical Optics, Inc. (AMO) is a global leader in the development,
manufacturing and marketing of ophthalmic surgical and eye care
products. The company focuses on developing a broad suite of
innovative technologies and devices to address a wide range of eye
disorders. Products in the ophthalmic surgical line include
intraocular lenses, phacoemulsification systems, viscoelastics,
microkeratomes and related products used in cataract and refractive
surgery. AMO owns or has the rights to such ophthalmic surgical
product brands as Phacoflex(R), Clariflex(R), Array(R), Sensar(R),
CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses,
Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification
systems with WhiteStar(TM) technology, Amadeus(TM) and Amadeus(TM)
II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the
Baerveldt(R) glaucoma shunt. Products in the contact lens care line
include disinfecting solutions, daily cleaners, enzymatic cleaners
and lens rewetting drops. Among the contact lens care product
brands the company possesses are COMPLETE(R) Moisture PLUS(TM),
COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step,
Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and
blink(TM) branded products. Amadeus is a licensed product of, and a
trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and
employs approximately 2,800 worldwide. The company has operations
in about 20 countries and markets products in approximately 60
countries. For more information, visit the company's Web site at
http://www.amo-inc.com/. Advanced Medical Optics, Inc. Investors:
Sheree Aronson (714) 247-8290
http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO
http://photoarchive.ap.org/ DATASOURCE: Advanced Medical Optics,
Inc. CONTACT: Investors, Sheree Aronson of Advanced Medical Optics,
Inc., +1-714-247-8290, Web site: http://www.amo-inc.com/
Copyright
Advanced medical Optics (NYSE:AVO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Advanced medical Optics (NYSE:AVO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Aveon Group LP Com USD0.01 da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Advanced Med Optics